| NTRA |
Natera, Inc. |
0 |
5.86% |
|
|
|
|
|
N/A |
0.00% |
53.42% |
16.92% |
|---|
| VCYT |
Veracyte, Inc. |
0 |
5.41% |
|
|
|
|
|
N/A |
0.00% |
62.23% |
31.55% |
|---|
| QGEN |
Qiagen N.V. |
0 |
4.66% |
|
|
|
|
|
N/A |
0.00% |
48.39% |
22.72% |
|---|
| TECH |
Bio-Techne Corporation |
0 |
4.57% |
|
|
|
|
|
N/A |
0.00% |
40.49% |
52.71% |
|---|
| BNTX |
BioNTech SE |
0 |
4.45% |
|
|
|
|
|
N/A |
0.00% |
45.15% |
32.29% |
|---|
| A |
Agilent Technologies, Inc. |
0 |
4.42% |
|
|
|
|
|
N/A |
0.00% |
26.04% |
25.40% |
|---|
| BMRN |
BioMarin Pharmaceutical Inc. |
0 |
4.10% |
|
|
|
|
|
N/A |
0.00% |
33.04% |
35.06% |
|---|
| ARWR |
Arrowhead Pharmaceuticals, Inc. |
0 |
4.10% |
|
|
|
|
|
N/A |
0.00% |
56.04% |
28.59% |
|---|
| ILMN |
Illumina, Inc. |
0 |
4.09% |
|
|
|
|
|
N/A |
0.00% |
41.31% |
22.70% |
|---|
| SRPT |
Sarepta Therapeutics, Inc. |
0 |
4.09% |
|
|
|
|
|
N/A |
0.00% |
82.04% |
56.49% |
|---|
| BEAM |
Beam Therapeutics Inc. |
0 |
3.76% |
|
|
|
|
|
N/A |
0.00% |
63.92% |
40.25% |
|---|
| CRSP |
CRISPR Therapeutics AG |
0 |
3.68% |
|
|
|
|
|
N/A |
0.00% |
54.77% |
39.68% |
|---|
| ALNY |
Alnylam Pharmaceuticals, Inc. |
0 |
3.51% |
|
|
|
|
|
N/A |
0.00% |
41.52% |
10.53% |
|---|
| RARE |
Ultragenyx Pharmaceutical Inc. |
0 |
3.39% |
|
|
|
|
|
N/A |
0.00% |
71.90% |
96.83% |
|---|
| LEGN |
Legend Biotech Corporation |
0 |
3.27% |
|
|
|
|
|
N/A |
0.00% |
65.05% |
22.13% |
|---|
| MRNA |
Moderna, Inc. |
0 |
3.23% |
|
|
|
|
|
N/A |
0.00% |
67.24% |
33.78% |
|---|
| TXG |
10x Genomics, Inc. |
0 |
2.97% |
|
|
|
|
|
N/A |
0.00% |
81.27% |
35.40% |
|---|
| RNA |
Avidity Biosciences, Inc. |
0 |
2.82% |
|
|
|
|
|
N/A |
0.00% |
67.15% |
53.95% |
|---|
| 1548.HK |
GENSCRIPT BIOTECH CORP |
|
2.76% |
|
|
|
|
|
|
|
|
|
|---|
| MYGN |
Myriad Genetics, Inc. |
0 |
2.47% |
|
|
|
|
|
N/A |
0.00% |
60.35% |
59.06% |
|---|
| NTLA |
Intellia Therapeutics, Inc. |
0 |
2.36% |
|
|
|
|
|
N/A |
0.00% |
84.48% |
58.18% |
|---|
| GILD |
Gilead Sciences, Inc. |
0 |
2.31% |
|
|
|
|
|
N/A |
0.00% |
45.18% |
73.01% |
|---|
| CDNA |
CareDx, Inc |
0 |
2.17% |
|
|
|
|
|
N/A |
0.00% |
110.71% |
21.02% |
|---|
| RCKT |
Rocket Pharmaceuticals, Inc. |
0 |
2.09% |
|
|
|
|
|
N/A |
0.00% |
217.96% |
72.73% |
|---|
| VRTX |
Vertex Pharmaceuticals Incorporated |
0 |
1.87% |
|
|
|
|
|
N/A |
0.00% |
29.42% |
23.44% |
|---|
| QURE |
uniQure N.V. |
0 |
1.59% |
|
|
|
|
|
N/A |
0.00% |
62.26% |
71.51% |
|---|
| VIR |
Vir Biotechnology, Inc. |
0 |
1.34% |
|
|
|
|
|
N/A |
0.00% |
70.90% |
44.75% |
|---|
| MRVI |
Maravai LifeSciences Holdings, Inc. |
0 |
1.33% |
|
|
|
|
|
N/A |
0.00% |
326.40% |
34.70% |
|---|
| PSTX |
POSEIDA THERAPEUTICS INC |
|
1.26% |
|
|
|
|
|
|
|
|
|
|---|
| SGMO |
Sangamo Therapeutics, Inc. |
0 |
0.96% |
|
|
|
|
|
N/A |
0.00% |
152.43% |
25.67% |
|---|
| PACB |
Pacific Biosciences of California, Inc. |
0 |
0.95% |
|
|
|
|
|
N/A |
0.00% |
120.73% |
46.31% |
|---|
| FLGT |
Fulgent Genetics, Inc. |
0 |
0.75% |
|
|
|
|
|
N/A |
0.00% |
88.61% |
38.41% |
|---|
| VERV |
Verve Therapeutics, Inc. |
0 |
0.71% |
|
|
|
|
|
N/A |
0.00% |
154.23% |
18.14% |
|---|
| RGNX |
REGENXBIO Inc. |
0 |
0.66% |
|
|
|
|
|
N/A |
0.00% |
652.49% |
29.91% |
|---|
| ALLO |
Allogene Therapeutics, Inc. |
0 |
0.59% |
|
|
|
|
|
N/A |
0.00% |
677.77% |
54.86% |
|---|
| SANA |
Sana Biotechnology, Inc. |
0 |
0.40% |
|
|
|
|
|
N/A |
0.00% |
214.00% |
21.37% |
|---|
| TSVT |
2seventy bio, Inc. |
0 |
0.29% |
|
|
|
|
|
N/A |
0.00% |
368.39% |
1.18% |
|---|
| CRBU |
Caribou Biosciences, Inc. |
0 |
0.27% |
|
|
|
|
|
N/A |
0.00% |
1,000.13% |
21.32% |
|---|
| EDIT |
Editas Medicine, Inc. |
0 |
0.20% |
|
|
|
|
|
N/A |
0.00% |
146.68% |
34.80% |
|---|
| LYEL |
Lyell Immunopharma, Inc. |
0 |
0.17% |
|
|
|
|
|
N/A |
0.00% |
279.25% |
17.57% |
|---|
| E |
Eni S.p.A. |
0 |
0.01% |
|
|
|
|
|
N/A |
0.00% |
34.22% |
36.94% |
|---|